Diamyd Medical AB (publ) (STO:DMYD.B)

Sweden · Delayed Price · Currency is SEK

1.056

+0.036 (3.53%)

Sep 2, 2026, 5:16 PM CET

Diamyd Medical AB Financials Overview

Financials in millions SEK. Fiscal year is September - August.

Millions SEK. Fiscal year is Sep - Aug.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Revenue	0.43	0.13	0.13	0.55	0.45	0.25
Revenue Growth	234.88%	0%	-76.19%	20.26%	79.45%	-25.81%
Gross Profit	-2.97	-3.71	-3.58	-3.09	-3.95	-2.25
Operating Income	-287.57	-183.23	-147.27	-115.85	-114.94	-86.07
Net Income	-283.65	-169.78	-151.85	-116.07	-103.52	60.05
Earnings Per Share	-2.01	-1.51	-1.60	-1.48	-1.35	0.86
EPS Growth	-	-	-	-	-	512.92%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Net Cash (Debt)	346.11	277.19	132.37	127.53	159.67	139.38
Net Cash Growth	8.41%	109.41%	3.79%	-20.13%	14.56%	103.88%
Net Cash Per Share	2.46	2.46	1.40	1.63	2.09	2.00
Cash & Investments	346.11	277.19	132.37	127.53	159.67	139.38

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Operating Cash Flow	-190.85	-169.68	-129.18	-110.96	-93.22	-109.47
Capital Expenditures	-3.18	-10.05	-8.03	-11.44	-34.65	-4.23
Free Cash Flow	-194.03	-179.73	-137.21	-122.4	-127.87	-113.69
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Gross Margin	-	-	-	-	-	-
Operating Margin	-66566.67%	-140949.23%	-113287.69%	-21217.22%	-25316.30%	-34020.55%
Pretax Margin	-65659.03%	-130597.69%	-116807.69%	-21258.79%	-22801.10%	23733.60%
Profit Margin	-65659.03%	-130597.69%	-116807.69%	-21258.79%	-22801.10%	23733.60%
FCF Margin	-44913.19%	-138254.61%	-105543.08%	-22418.32%	-28165.42%	-44937.94%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
PE Ratio	-	-	-	-	-	40.17
Forward PE	-	129.14	260.00	260.00	260.00	260.00
PS Ratio	378.85	11951.90	12595.78	1538.11	2470.47	9533.21